Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis [Phase 1]
This is a first-in-human Phase 1 study to evaluate REGN20423 in healthy adult participants and adults with atopic dermatitis; the trial is n…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
This document reports a Phase 2 clinical trial evaluating JNJ-95597528 for moderate to severe atopic dermatitis, currently recruiting partic…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor [Phase 3]
Phase 3 clinical trial evaluating subcutaneous amlitelimab for moderate-to-severe atopic dermatitis in patients 12 and older with inadequate…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis [Phase 2]
This clinical trial update describes a long-term extension study to evaluate the safety and efficacy of Afimkibart (RO7790121) in participan…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials [Phase 2, Phase 3]
A clinical trial update reports long-term safety and efficacy evaluation of amlitelimab in participants from prior atopic dermatitis trials,…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)
A French prospective observational study in patients eligible for systemic therapy for atopic dermatitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Clinical Evaluation of Skin Microbiome an Over-The-Counter (OTC) Drug for Atopic Dermatitis [Phase 1]
Phase 1 clinical trial evaluating a skin microbiome-based OTC product for atopic dermatitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 Weeks [NA]
A randomized controlled trial comparing topical tacrolimus 0.03% with crisaborole 2% for mild to moderate atopic dermatitis over 8 weeks; th…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Characterization of Chronic Hand Eczema
A clinical trial is characterizing chronic hand eczema and is currently recruiting participants.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Metabolic Profiling of Immune Responses in Immune-mediated Diseases
A clinical trial update from NIAID announces ongoing recruitment for a study investigating metabolic profiling of immune responses in immune…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica
A Costa Rican clinical trial is evaluating the treatment of atopic dermatitis with dupilumab in combination with JAK inhibitors; the study i…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
This Phase 2 trial assesses the efficacy and safety of Afimkibart (RO7790121) in participants with moderate to severe atopic dermatitis and …
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial is evaluating the efficacy and safety of SHR-1905 for moderate-to-severe atopic dermatitis and is currently recruit…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis [Phase 2]
Phase 2 clinical trial evaluating SHR-1819 for moderate-to-severe atopic dermatitis; actively recruiting.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients [Phase 1]
Pfizer's first-in-human Phase 1 study is evaluating the tolerability of PF-07832837 in healthy adults and in patients with atopic dermatitis…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Studies of Skin Microbes in Healthy People and in People With Skin Conditions
A National Human Genome Research Institute-sponsored clinical trial is recruiting to study skin microbes in healthy people and in individual…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema [Phase 3]
Pfizer is conducting a long-term Phase 3 study of Abrocitinib for moderate-to-severe atopic dermatitis in children aged 2 years and older; t…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis [Phase 3]
Phase 3 clinical trial update for SHR-1819 Injection in adolescents with moderate-to-severe atopic dermatitis. The study is currently recrui…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Effects of Treatments on Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial sponsored by NIAMS is evaluating treatments for atopic dermatitis (eczema) and related dermatitis conditions, curre…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis [Phase 3]
A Phase 3 study evaluating adverse events and changes in disease activity comparing oral upadacitinib with subcutaneous dupilumab in childre…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema [Phase 3]
Pfizer is conducting a Phase 3 study of abrocitinib in children aged 6 to less than 12 years with moderate-to-severe eczema, and the trial i…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Registry for Systemic Eczema Treatments
A Johns Hopkins University clinical trial registry entry for Atopic Dermatitis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Clinical Study to Evaluate SM17 for Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial evaluating SM17 for atopic dermatitis is currently recruiting; no results are reported yet.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2a trial evaluating the efficacy, safety, and tolerability of GIA632 in adults with moderate-to-severe atopic dermatitis; recruitment …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants [Phase 1]
A Phase 1 clinical trial evaluating SKB575 (HBM7575) injections in healthy participants and participants with atopic dermatitis is currently…